Watch Global Investment Strategist Simeon Hyman, CFA with @CNBC's Frank Holland as he explains how earnings and market dynamics are supportive for small-caps, even amid geopolitical noise: proshares.us/3I8hDwE
Learn more about small-cap exposure with ITWO and view its current…
This month, we're celebrating the 10-year anniversary of the ProShares Ex-Sector ETFs listing on @NYSE. Learn how these strategies can help investors tailor their core S&P 500 exposure: proshares.us/3UWBUbn
Watch Global Investment Strategist Simeon Hyman, CFA on 'What's the Fund?' as he highlights our recent launch of CRCA, the first ETF to target 2x the daily returns of Circle.
Learn more: proshares.us/4lQ5Qkr
We're excited to introduce the only ETF that targets 2x the daily returns of the S&P 500 Equal Weight Index. Seek magnified returns of S&P 500 companies in a more balanced way with URSP. Learn more: proshares.us/4oV8VSU
For investors looking to hedge against inflation and diversify beyond traditional equity and fixed income, companies managing vital assets like utilities, energy networks, and transportation offer a compelling opportunity. Learn more about the case for pure-play infrastructure:…
Is Health Care undervalued—or are regulatory and trade headwinds dimming its outlook? We unpack this question in our latest Quick Take: proshares.us/4mX9Q3z
Global Investment Strategist Simeon Hyman, CFA joined Ethan Hertzfeld on 'What's the Fund?' to highlight our recent launch of SLON and UXRP. These ETFs target 2x the daily returns of Solana and XRP, respectively. Learn more: proshares.us/4oJVsNO
These funds invest in…
In our latest commentary, Global Investment Strategist Simeon Hyman, CFA explains how softening labor markets increase the odds of a Fed rate cut, why long-term yields may still rise, and the case for a less rate-sensitive income strategy. Learn more: proshares.us/45FwQx1
Introducing QQXL, the first and only ETF that targets 2x the daily returns of the Nasdaq-100 Top 30 Index. QQXL offers magnified exposure to 30 of the largest and most innovative companies shaping the future. Learn more: proshares.us/4oDH6P0
Signs of a cooling labor market have heightened expectations for a rate cut. Explore what this could mean for markets in our latest commentary: proshares.us/3UYRKlI
Global Investment Strategist Simeon Hyman, CFA appeared on @FoxBusiness with Cheryl Casone to discuss labor market softening, the Fed’s shifting role, and strong earnings growth in the Nasdaq-100. Watch the full interview here: proshares.us/46MmkWY
Explore IQQQ, a covered…
Thanks to our friends at @NYSE for helping us celebrate the launch of CRCA, the first ETF targeting 2x the daily returns of Circle. Learn more: proshares.us/4mqVAQZ
🗓️ The latest distributions for our S&P 500 High Income ETF (ISPY), our Nasdaq-100 High Income ETF (IQQQ) and our Russell 2000 High Income ETF (ITWO) are in. Click to learn more (as of 6/30/25).
Performance & Details: proshares.us/ISPY, proshares.us/IQQQ, &…
We're excited to introduce CRCA—ProShares Ultra CRCL—the first ETF targeting 2x the daily returns of Circle (CRCL), a leader in USD-backed stablecoins. Learn more: proshares.us/3UCKn3v
📆 Webcast Reminder: Thu, 8/7 | 2PM ET
Join ProShares' Simeon Hyman, CFA and Kieran Kirwan, CAIA, for a timely discussion on navigating rising yields with equity strategies designed to balance income-generating potential and long-term upside. Sign up here: proshares.us/4oGyMOH
Health care trailed the S&P 500 in 2023 and 2024, rising less than 3% as the index gained over 20% annually — a trend that’s continued this year. Explore how SPXV lets you maintain core S&P 500 exposure while mitigating the impact of a recently underperforming sector.…
The bond market is signaling concern over spending and inflation. Join ProShares' Simeon Hyman, CFA and Kieran Kirwan, CAIA for a discussion on equity strategies designed to balance income-generating potential and long-term upside. Sign up here: proshares.us/4otw5jp
104 Followers 1K FollowingFrom the Chesapeake to your late night cravings 😈
Maryland girl with big mood energy and a soft spot for trouble.
Come baby it’s FREE⬇️
345 Followers 930 FollowingHead of Life Sciences for CBRE. Founder of California Biomanufacturing Center, data startups SageLegion, Cancer Commons, PL-X, prior CEO of BayBio.
862 Followers 1K FollowingOur doubts are traitors, and make us lose the good we oft might win, by fearing to attempt - Shakespeare; Joshua 1:9; Luke 1:46-47; Psalm 51; 62:5-8; 🎗️💙
3K Followers 511 FollowingProud father of two. Former consultant to financial planners before becoming one. Educator. Filler of planning gaps. Fiduciary. Attitude of gratitude. Dad life.
16K Followers 872 FollowingYour daily guide to markets, data and disruption. Start a 2-week FREE trial on our site to receive one of Wall Street's most followed daily market commentaries!
12K Followers 3K FollowingColumnist at The Wall Street Journal's Heard on the Street (@WSJ). Vaig cobrir la presentació oficial de Bananity i he pujat a dins d'un Lilium Jet.
1K Followers 264 FollowingLori Ioannou is an award-winning journalist and digital content strategist. She covers technology, small business, health, careers, investing and global risk.
50K Followers 3K FollowingCovering markets & money @WSJ, Contributor @CNBC. Dancer. New Yorker. Reach me at [email protected]
On instagram @ gunjansb. Views are my own.
30K Followers 984 FollowingSenior Markets Columnist at the Wall Street Journal. Ex FT Investment Editor (writer of Short View). Retweets not endorsements. Views mine. Bluesky mainly now
73K Followers 3K FollowingAward-winning writer of @TKerLLC, the newsletter about how the stock market usually goes up. 33k+ subs. Long-term optimist. Short-term cautious optimist.
2K Followers 490 FollowingDeputy editor of the FT's EM Squared. Likes things with a k in them - cricket, punk, ska and blackcurrant cheesecake. Unsurprisingly, all views are my own.
1K Followers 351 FollowingTax analyst. ETFs, direct indexing, long/short, bonds, options, you name it. Former Zillow software, Parametric software, PIMCO trade floor.
63K Followers 87 FollowingFinancial writer. Markets & charts. Subscribe for exclusive charts, a daily insight, and a follow-back. Open to freelance or full-time work.
4K Followers 654 FollowingMarketWatch columnist. Cabot. Stock letter: https://t.co/OURT9jAARf. 🚫 consensus. Prior: NYT Business Economist Group MSN Columbia Biz Schl, Hopkins SAIS Italy.
14K Followers 1K FollowingPersonal finance and management editor for IBD. Watcher of financial markets. Author of Investing Online and Fundamental Analysis for Dummies. Views are my own.
7K Followers 506 FollowingWrote on 30-plus sports plus #stocks & #economics at Kyodo News in #Japan, 1994-99. Now #IBDLive cohost, deputy markets editor at IBD @IBD_DChung
No recent Favorites. New Favorites will appear here.